A$
0.40
Nov 28
Business Description
SomnoMed Ltd
SIC : 3840
ISIN : AU000000SOM1
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.41 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -2.56 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.15 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.6 | |||||
3-Year EPS without NRI Growth Rate | -116.2 | |||||
3-Year FCF Growth Rate | -95.4 | |||||
3-Year Book Growth Rate | -11.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.27 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 85.97 | |||||
9-Day RSI | 77.43 | |||||
14-Day RSI | 69.59 | |||||
6-1 Month Momentum % | 20 | |||||
12-1 Month Momentum % | -6.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.76 | |||||
Quick Ratio | 1.45 | |||||
Cash Ratio | 0.81 | |||||
Days Inventory | 50.68 | |||||
Days Sales Outstanding | 34.98 | |||||
Days Payable | 121.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.9 | |||||
Shareholder Yield % | -45.39 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.15 | |||||
Operating Margin % | -9.09 | |||||
Net Margin % | -13.36 | |||||
FCF Margin % | -12.74 | |||||
ROE % | -37.73 | |||||
ROA % | -18.72 | |||||
ROIC % | -22.2 | |||||
ROC (Joel Greenblatt) % | -64.37 | |||||
ROCE % | -17.95 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.53 | |||||
PB Ratio | 1.86 | |||||
Price-to-Tangible-Book | 3.29 | |||||
EV-to-EBIT | -9.04 | |||||
EV-to-EBITDA | -28.89 | |||||
EV-to-Revenue | 0.84 | |||||
EV-to-FCF | -4.37 | |||||
Price-to-Median-PS-Value | 0.21 | |||||
Price-to-Net-Current-Asset-Value | 7.9 | |||||
Earnings Yield (Greenblatt) % | -11.07 | |||||
FCF Yield % | -13.67 | |||||
Forward Rate of Return (Yacktman) % | 6.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
SomnoMed Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 91.652 | ||
EPS (TTM) (A$) | -0.102 | ||
Beta | 1.46 | ||
Volatility % | 82.54 | ||
14-Day RSI | 69.59 | ||
14-Day ATR (A$) | 0.024581 | ||
20-Day SMA (A$) | 0.293 | ||
12-1 Month Momentum % | -6.28 | ||
52-Week Range (A$) | 0.19 - 0.47 | ||
Shares Outstanding (Mil) | 216.11 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SomnoMed Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SomnoMed Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
SomnoMed Ltd Frequently Asked Questions
What is SomnoMed Ltd(ASX:SOM)'s stock price today?
When is next earnings date of SomnoMed Ltd(ASX:SOM)?
Does SomnoMed Ltd(ASX:SOM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |